Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China · Delayed Price · Currency is CNY 42.93
+0.38 (0.89%)
Jan 23, 2026, 3:00 PM CST
SHA:603590 Market Cap
SHA:603590 has a market cap or net worth of 6.77 billion as of January 22, 2026. Its market cap has increased by 77.50% in one year.
Market Cap
6.77B
Enterprise Value
6.42B
Revenue
871.31M
Ranking
n/a
PE Ratio
117.01
Stock Price
42.93
Market Cap Chart
Since August 27, 2018, SHA:603590's market cap has increased from 5.61B to 6.77B, an increase of 20.65%. That is a compound annual growth rate of 2.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 6.77B | 7.04% |
| Dec 31, 2025 | 6.32B | 69.72% |
| Dec 31, 2024 | 3.72B | -37.51% |
| Dec 29, 2023 | 5.96B | 52.69% |
| Dec 30, 2022 | 3.90B | -23.24% |
| Dec 31, 2021 | 5.08B | -12.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wuhan Keqian Biology Co.,Ltd | 7.62B |
| GemPharmatech | 7.52B |
| Suzhou Fengbei Biotech Stock | 7.26B |
| R&G PharmaStudies | 6.72B |
| Kexing Biopharm | 6.67B |
| Xiangxue Pharmaceutical | 6.67B |
| Jiangsu Bioperfectus Technologies | 6.48B |
| Shanghai OPM Biosciences | 6.43B |